Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Smirnova, N. Mitushkina, O. Suhovskaya, E. Imyanitov (Saint-Petersburg, Russian Federation). Association between dopamine transporter, monoamine oxidases genotypes and tobacco smoking. Eur Respir J 2011; 38: Suppl. 55, 1105

Member's Comments

No comment yet.

Related content which might interest you: Relationship between cigarette (nicotine) addiction and dopamine receptor D2 gene variants (TaqlA and -141C Ins/ Del) Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Serotonin system in smoking addiction: the role of T102C polymorphism of the 5HT2A receptor gene Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004 Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms Source: Eur Respir J 2006; 27: 289-292 Year: 2006 NADPH oxidases are regulated in a mouse model of tobacco smoke induced COPD Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 New drug for smoking cessation: varenicline Source: Annual Congress 2005 - New strategies and drugs for smoking cessation Year: 2005 Influence of polymorphic variants of DRD2 and SLC6A3 genes and their combinations on smoking habit in Polish population Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 Is the 5HT2A polymorphism the link between smoking and depression? Source: Annual Congress 2007 - The versatile aspects of nicotine addiction Year: 2007 Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking Source: Eur Respir J 2004; 23: 214-218 Year: 2004 Mitochondrial dehydrogenase activity as a measure of tobacco smoke toxicity Source: Annual Congress 2007 - The versatile aspects of nicotine addiction Year: 2007 Analysis of CYP2A6 and CYP2A13 genes using new generation sequencing method in smokers and non-smokers. Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 The dopamine receptor D4 VNTR 48bp gene variant in nicotine addiction Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 New drug for smoking cessation: rimonabant Source: Annual Congress 2005 - New strategies and drugs for smoking cessation Year: 2005 Pharmacological treatments for tobacco dependence Source: Eur Respir Rev 2008; 17: 192-198 Year: 2008 Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 The victim potential of sitaxentan: metabolism by human CYP450 enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 The CYP2A6 gene polymorphism in male Bataknese smoker lung cancer patients and its association with nicotine dependence Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase1 activity in healthy people Source: Eur Respir J 2005; 26: Suppl. 49, 153s Year: 2005 Polymorphism of the serotonin transporter and 2a receptor gene in COPD with and without pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008